Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › platelet-rich plasma (PRP)

platelet-rich plasma (PRP)

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials of platelet-rich plasma (PRP)

3 trials tracked of platelet-rich plasma (PRP).

3Trials tracked
0Phase 3 & 4
0Recruiting
0With published results
Phase distribution
Phase 1 1 Other / NA 2
  1. Phase 1 Shockwave Therapy and Platelet Rich Plasma for the Treatment of Erectile Dysfunction Completed
  2. N/A Intra Articular Injections With Platelet Rich Plasma in Patients With Juvenile Osteochondritis Dissecans of the Knee Completed
  3. N/A Hyaluronic Acid vs Platelet Rich Plasma: Effects on Clinical Outcomes and Intra-articular Biology for the Treatment of Knee Osteoarthritis Completed

Showing the 3 most-cited and recently-updated of 3 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
PRP growth factors converge on PI3K–AKT and MAPK pathways in ovarian follicular development
OB/GYN & Women's Health Sys. Review
PRP growth factors converge on PI3K–AKT and MAPK pathways in ovarian follicular development PRP may boost ovarian signaling pathways, study finds
A systematic mechanistic review and computational pathway analysis found that growth factors in platelet-rich plasma (PRP) converge on PI3K–…
A computational analysis suggests PRP may activate key ovarian signaling pathways, but does not replace natural follicle development.
Frontiers Jul 30, 2026